News
Important Only
Still questions before return to Suez Canal, German car industry says
FRANKFURT, Jan 16 (Reuters) - The German automotive industry is still seeing open questions, particularly insurance issues, before resuming transports through the Suez Canal, its business association VDA said on Friday."The top priority for everyone involved is the absolute safety of the crews -...Reuters
Fri, Jan 16
Hillenbrand Inc - For Three Months Ended Dec 31, Net Revenue Estimated Between $540 Million And $560 Million - SEC Filing
Jan 16 (Reuters) - Hillenbrand Inc HI.N:FOR THREE MONTHS ENDED DEC 31, NET REVENUE ESTIMATED BETWEEN $540 MILLION AND $560 MILLION - SEC FILINGQ1 REVENUE VIEW $583.7 MILLION -- LSEG IBES DATASource text: [ID:n0001104659-26-004328]Further company coverage: HI.NReuters
Fri, Jan 16
EHang Appoints Mr. Shuai Feng As Chief Technology Officer To Deepen Technological Innovation And Industrial Synergy, Empowering Commercialization
Jan 16 (Reuters) - EHang Holdings Ltd EH.O:EHANG APPOINTS MR. SHUAI FENG AS CHIEF TECHNOLOGY OFFICER TO DEEPEN TECHNOLOGICAL INNOVATION AND INDUSTRIAL SYNERGY, EMPOWERING COMMERCIALIZATIONReuters
Fri, Jan 16
High Roller Technologies Signs Letter Of Intent For Strategic Marketing Agreement With Forever Network To Amplify U.S. Prediction Markets Launch
Jan 16 (Reuters) - High Roller Technologies Inc ROLR.A:HIGH ROLLER TECHNOLOGIES SIGNS LETTER OF INTENT FOR STRATEGIC MARKETING AGREEMENT WITH FOREVER NETWORK TO AMPLIFY U.S. PREDICTION MARKETS LAUNCHReuters
Fri, Jan 16
VivoPower’s Tembo Secures Strategic Partnership in US$11 Billion Australian Utility Pick Up Truck Market with EV Industry Leader HMBEV
Jan 16 (Reuters) - VivoPower International PLC VVPR.O:VIVOPOWER’S TEMBO SECURES STRATEGIC PARTNERSHIP IN US$11 BILLION AUSTRALIAN UTILITY PICK UP TRUCK MARKET WITH EV INDUSTRY LEADER HMBEVVIVOPOWER INTERNATIONAL PLC - PARTNERSHIP AIMS TO DRIVE MARKET ADOPTION IN AUSTRALIAReuters
Fri, Jan 16
FedEx Announces Filing Of Form 10 Registration Statement For Planned Spin-Off Of Fedex Freight
Jan 16 (Reuters) - FedEx Corp FDX.N:FEDEX ANNOUNCES FILING OF FORM 10 REGISTRATION STATEMENT FOR PLANNED SPIN-OFF OF FEDEX FREIGHTFEDEX: SEPARATION ON TRACK FOR COMPLETION ON JUNE 1, 2026FEDEX: FEDEX FREIGHT'S STOCK EXPECTED TO BE LISTED ON NYSE UNDER TICKER SYMBOL "FDXF"Reuters
Fri, Jan 16
Sinclair Provides Update On Merger Proposal Discussions With The E.W. Scripps Company
Jan 16 (Reuters) - Sinclair Inc SBGI.O:SINCLAIR PROVIDES UPDATE ON MERGER PROPOSAL DISCUSSIONS WITH THE E.W. SCRIPPS COMPANYSINCLAIR INC - SCRIPPS REFUSES TO ENGAGE WITH SINCLAIR, PREFERS STANDALONE PLANSINCLAIR INC - CONTINUES STRATEGIC REVIEW OF BROADCAST BUSINESSReuters
Fri, Jan 16
New Clinical Data Highlights Caplyta® (Lumateperone) As A Promising Option For Achieving Remission In Adults With Major Depressive Disorder
Jan 16 (Reuters) - Johnson & Johnson JNJ.N:NEW CLINICAL DATA HIGHLIGHTS CAPLYTA® (LUMATEPERONE) AS A PROMISING OPTION FOR ACHIEVING REMISSION IN ADULTS WITH MAJOR DEPRESSIVE DISORDERJ&J - 65% REACHED REMISSION WITH CAPLYTA, 43% SUSTAINED RELIEF IN SIX MONTHSReuters
Fri, Jan 16
Fedex - Unit Enters $1.2 Billion Revolving Credit Facility - SEC Filing
Jan 16 (Reuters) - FedEx Corp FDX.N:FEDEX - UNIT ENTERS $1.2 BILLION REVOLVING CREDIT FACILITY - SEC FILINGFEDEX - UNIT ENTERS $600 MILLION TERM LOAN FACILITY - SEC FILINGFEDEX - UNIT CAN INCREASE REVOLVING CREDIT FACILITY BY $600 MILLION - SEC FILINGFEDEX - REVOLVING CREDIT FACILITY CONDITIONED ON ...Reuters
Fri, Jan 16
RPT-BREAKINGVIEWS-Boston Scientific deal is too rich for its blood
By Robert CyranNEW YORK, Jan 15 (Reuters Breakingviews) - To justify its latest mega-deal, Boston Scientific BSX.N will soon be reaching for a defibrillator. The medical device manufacturer is paying $15 billion to buy Penumbra, whose products help remove blood clots, to beef up its cardiovascular p...Reuters
Fri, Jan 16
ADVISORY-Alert and brief on health platform Shed withdrawn (January 14)
An alert and a Brief item, filed on January 14, on health and wellness platform Shed introducing Wegovy pills in its GLP-1 weight loss programs have been withdrawn after the company said its statement should be disregarded.There will be no substitute.STORY_NUMBER: nFWN3YF1XLSTORY_DATE: January 14, 2...Reuters
Fri, Jan 16
Arbutus Biopharma Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC Filing
Jan 16 (Reuters) - Arbutus Biopharma Corp ABUS.O:ARBUTUS BIOPHARMA CORP - EPO REVOKES ARBUTUS BIOPHARMA'S EUROPEAN PATENT EP 2279254 - SEC FILINGARBUTUS BIOPHARMA CORP - DECISION LIKELY TO AFFECT ARBUTUS CASE AGAINST MODERNA IN SWITZERLAND - SEC FILINGARBUTUS BIOPHARMA CORP - EXPECTS NO IMPACT O...Reuters
Fri, Jan 16
